URO ONCO

Welcome, this website is intended for all international healthcare professionals in uro-oncology. By clicking the link below you are declaring and confirming that you are a healthcare professional.

You are here

Interview at EMUC 2014 with Prof. Bertrand Tombal, Brussels, Belgium

Should primary cancer be treated in metastatic patients?

TOMBAL URO ONCO

The metastatic clone cannot yet be identified in the primary tumor. Circulating tumor cells in localized disease are rare and could not earlier be used to predict metastases. Phase II data suggests that local treatment in metastasized prostate cancer may be beneficial, and retrospective data suggests that men with a prior local treatment had a better outcome in the metastasized stage. Stronger evidence from phase III trials is needed to support the use of local treatment in metastasized disease.

E-Alert

Subscribe to our E-Alert to keep up to date with the new items in the Resource Centre

Subscribe

URO ONCO is made possible by an unrestricted educational grant from:

The editorial independence of the resource centre is mandatory and recognized by the EAU and Elsevier.

The journal articles, videos and statements published on the resource centre have been selected independently and without influence from Elsevier, European Urology Editors or the sponsor and do not necessarily reflect their opinions or views.